Literature DB >> 15480796

Extracellular matrix distribution and islet morphology in the early postnatal pancreas: anomalies in the non-obese diabetic mouse.

Sacha Brigitte Geutskens1, Françoise Homo-Delarche, Jean-Marie Pleau, Sylvie Durant, Hemmo Arjan Drexhage, Wilson Savino.   

Abstract

Previously, we reported elevated numbers of macrophages in the pancreas of NOD mice, a spontaneous animal model for T1D, during the early postnatal period. Extracellular matrix plays an important role in the tissue trafficking and retention of macrophages as well as in postnatal pancreas development. Therefore, we have examined the expression and distribution of laminin and fibronectin, two major extracellular matrix proteins and their corresponding integrin receptors, in the pre-weaning pancreases of NOD mice and control mouse strains. In addition, we have characterized the pancreas morphology during this period, since the morphology of the pre-weaning pancreas before the onset of lymphocytic peri-insulitis, when the pancreas is still subject to developmental changes, has been poorly documented. We show that laminin labeling is mainly associated with exocrine tissue, whereas fibronectin labeling was mostly localized at the islet-ductal pole, islet periphery and in intralobular septa. Moreover, the protein expression level of fibronectin was increased in NOD pancreases at the early stage of postnatal development, as compared to pancreases of C57BL/6 and BALB/c mouse strains. Interestingly, pancreatic macrophages were essentially found at sites of intense fibronectin labeling. The increased fibronectin content in NOD neonatal pancreas coincided with altered islet morphology, histologically reflected by enlarged and irregular shaped islets and increased percentages of total endocrine area as compared to that of control strains. In conclusion, increased levels of the extracellular matrix protein fibronectin were found in the early postnatal NOD pancreas, and this is associated with an enhanced accumulation of macrophages and altered islet morphology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480796     DOI: 10.1007/s00441-004-0989-0

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  13 in total

1.  The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  J Liver       Date:  2013

2.  Small intestinal submucosa improves islet survival and function during in vitro culture.

Authors:  Xiao-Hui Tian; Wu-Jun Xue; Xiao-Ming Ding; Xin-Lu Pang; Yan Teng; Pu-Xun Tian; Xin-Shun Feng
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Functional mapping of disease susceptibility loci using cell biology.

Authors:  Peter A Antinozzi; Alejandro Garcia-Diaz; Chuan Hu; James E Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-28       Impact factor: 11.205

4.  Syndecan-4 is associated with beta-cells in the pancreas and the MIN6 beta-cell line.

Authors:  Jennifer Y C Cheng; John Whitelock; Laura Poole-Warren
Journal:  Histochem Cell Biol       Date:  2012-08-08       Impact factor: 4.304

5.  An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.

Authors:  G Bouma; J M C Coppens; W-K Lam-Tse; W Luini; K Sintnicolaas; W H Levering; S Sozzani; H A Drexhage; M A Versnel
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

6.  Glucose homeostasis in pre-diabetic NOD and lymphocyte-deficient NOD/SCID mice during gestation.

Authors:  Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2010-05-10

7.  The Langerhans islet cells of female rabbits are differentially affected by hypothyroidism depending on the islet size.

Authors:  J Rodríguez-Castelán; L Nicolás; S Morimoto; E Cuevas
Journal:  Endocrine       Date:  2014-09-12       Impact factor: 3.633

Review 8.  Signals in the pancreatic islet microenvironment influence β-cell proliferation.

Authors:  Kristie I Aamodt; Alvin C Powers
Journal:  Diabetes Obes Metab       Date:  2017-09       Impact factor: 6.577

9.  Conversion of the death inhibitor ARC to a killer activates pancreatic β cell death in diabetes.

Authors:  Wendy M McKimpson; Yun Chen; James A Irving; Min Zheng; Jeremy Weinberger; Wilson Lek Wen Tan; Zenia Tiang; Alistair M Jagger; Streamson C Chua; Jeffrey E Pessin; Roger S-Y Foo; David A Lomas; Richard N Kitsis
Journal:  Dev Cell       Date:  2021-03-04       Impact factor: 12.270

10.  Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases.

Authors:  John R B Perry; Benjamin F Voight; Loïc Yengo; Najaf Amin; Josée Dupuis; Martha Ganser; Harald Grallert; Pau Navarro; Man Li; Lu Qi; Valgerdur Steinthorsdottir; Robert A Scott; Peter Almgren; Dan E Arking; Yurii Aulchenko; Beverley Balkau; Rafn Benediktsson; Richard N Bergman; Eric Boerwinkle; Lori Bonnycastle; Noël P Burtt; Harry Campbell; Guillaume Charpentier; Francis S Collins; Christian Gieger; Todd Green; Samy Hadjadj; Andrew T Hattersley; Christian Herder; Albert Hofman; Andrew D Johnson; Anna Kottgen; Peter Kraft; Yann Labrune; Claudia Langenberg; Alisa K Manning; Karen L Mohlke; Andrew P Morris; Ben Oostra; James Pankow; Ann-Kristin Petersen; Peter P Pramstaller; Inga Prokopenko; Wolfgang Rathmann; William Rayner; Michael Roden; Igor Rudan; Denis Rybin; Laura J Scott; Gunnar Sigurdsson; Rob Sladek; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Jaakko Tuomilehto; Andre G Uitterlinden; Sidonie Vivequin; Michael N Weedon; Alan F Wright; Frank B Hu; Thomas Illig; Linda Kao; James B Meigs; James F Wilson; Kari Stefansson; Cornelia van Duijn; David Altschuler; Andrew D Morris; Michael Boehnke; Mark I McCarthy; Philippe Froguel; Colin N A Palmer; Nicholas J Wareham; Leif Groop; Timothy M Frayling; Stéphane Cauchi
Journal:  PLoS Genet       Date:  2012-05-31       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.